Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (4): 49-54.doi: 10.6040/j.issn.1673-3770.0.2021.278

Previous Articles    

Prevalence and prognostic nomogram for IVc stage hypopharyngeal carcinoma patients: a SEER population-based analysis

JIANG Chao, ZHOU Xuanchen, HAN Jie, YUE Zhiyong   

  1. Department of Otorhinolaryngology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, Shandong, China
  • Published:2022-07-11

Abstract: Objective Hypopharyngeal carcinoma patients in IVc stage are always associated with poor prognosis and prognostic factors for these patients are largely unknown. We aimed to characterize the prevalence of metastases, and establish a prognostic nomogram for survival prediction. Methods Hypopharyngeal carcinoma patients with IVc stage were collected from surveillance, epidemiology and End Results(SEER)database. Chi-square test was used to analyze the related risk factors of different sites of metastases. Univariate and multivariate Cox regression analyses were performed to analyze the prognostic factors of cancer-specific survival(CSS)in IVc stage patients. The nomogram based on multivariate Cox analysis was then established and validated. Results A total of 283 IVc stage hypopharyngeal carcinoma patients were included in this study. Majority of patients were diagnosed with single metastasis, and lung(53. 7%)was the most common metastasis site. Patients with tumor in pyriform sinus(P=0.029)and high-grade tumors(P=0.010)were more likely to develop lung metastasis. Multivariate Cox analysis showed that bone metastasis(HR=2.239, P<0.001), liver metastasis (HR=1.880, P=0.003), surgical therapy(HR=0.311, P=0.003)and chemotherapy(HR=0.494, P<0.001)were independent prognostic factors for CSS. Independent prognostic factors were integrated into nomogram for CSS prediction, and the C-index was 0.686(95%CI 0.649-0.723). Conclusion Lung metastasis is the most common in IVc stage hypopharyngeal carcinoma patients. For hypopharyngeal carcinoma patients in IVc stage, surgical therapy, chemotherapy, without bone and liver metastases are associated with superior survival outcome. The proposed nomogram has a good predictive ability and may be practical for clinical decision-making.

Key words: Hypopharyngeal carcinoma, Nomogram, Surveillance, Epidemiology, and End Results, Distant metastases

CLC Number: 

  • R739.6
[1] Li Y, Ou X, Hu C. Prevalence and prognostic impact of synchronous distant metastases in patients with hypopharynx squamous cell carcinomas: a SEER-based study[J]. J Cancer, 2019, 10(3): 620-626. doi:10.7150/jca.28554.
[2] Eckel HE, Bradley PJ. Natural history of treated and untreated hypopharyngeal cancer[J]. Adv Otorhinolaryngol, 2019, 83: 27-34. doi:10.1159/000492305.
[3] Pai SI, Faivre S, Licitra L, et al. Comparative analysis of the phase III clinical trials of anti-PD1 monotherapy in head and neck squamous cell carcinoma patients(CheckMate 141 and KEYNOTE 040)[J]. J Immunother Cancer, 2019, 7(1): 96. doi:10.1186/s40425-019-0578-0.
[4] McGranahan N, Swanton C. Biological and therapeutic impact of intratumor heterogeneity in cancer evolution[J]. Cancer Cell, 2015, 27(1): 15-26. doi:10.1016/j.ccell.2014.12.001.
[5] McGranahan N, Swanton C. Clonal heterogeneity and tumor evolution: past, present, and the future[J]. Cell, 2017, 168(4): 613-628. doi:10.1016/j.cell.2017.01.018.
[6] Wiegand S, Zimmermann A, Wilhelm T, et al. Survival after distant metastasis in head and neck cancer[J]. Anticancer Res, 2015, 35(10): 5499-5502.
[7] Liu JC, Bhayani M, Kuchta K, et al. Patterns of distant metastasis in head and neck cancer at presentation: Implications for initial evaluation[J]. Oral Oncol, 2019, 88: 131-136. doi:10.1016/j.oraloncology.2018.11.023.
[8] Spector JG, Sessions DG, Haughey BH, et al. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx[J]. Laryngoscope, 2001, 111(6): 1079-1087. doi:10.1097/00005537-200106000-00028.
[9] Suzuki A, Kashiwagi N, Doi H, et al. Patterns of bone metastases from head and neck squamous cell carcinoma[J]. Auris Nasus Larynx, 2020, 47(2): 262-267. doi:10.1016/j.anl.2019.08.001.
[10] Bollig CA, Newberry CI, Galloway TLI, et al. Prognostic impact of metastatic site and pattern in patients with metastatic head and neck cancer[J]. Laryngoscope, 2021, 131(6): E1838-E1846. doi:10.1002/lary.29208.
[11] Perrakis A, Juratli TA, Hohenberger W, et al. Surgery for metastases, anatomical and ethical limits. Special aspect: oligometastases[J]. Der Chir Zeitschrift Fur Alle Gebiete Der Oper Medizen, 2016, 87(3): 208-215. doi:10.1007/s00104-015-0147-0.
[12] 崔晓波. 诱导化疗在局部晚期下咽癌治疗中的意义[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 10-17.doi: 10.1016/j.anl.2019.08.001. CUI Xiaobo. Significance of induction chemotherapy in late treatment of locally advanced hypo-pharyngeal cancer[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 10-17.doi: 10.1016/j.anl.2019.08.001.
[13] Kuo P, Sosa JA, Burtness BA, et al. Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base[J]. Cancer, 2016, 122(12): 1853-1860. doi:10.1002/cncr.29962.
[14] Vincent AG, Wang W, Shokri T, et al. Treatment of oligometastatic disease in squamous cell carcinoma of the head and neck[J]. Laryngoscope, 2021, 131(5): E1476-E1480. doi:10.1002/lary.29115.
[15] Oweira H, Petrausch U, Helbling D, et al. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: a Surveillance Epidemiology and End Results database analysis[J]. World J Gastroenterol, 2017, 23(10): 1872-1880. doi:10.3748/wjg.v23.i10.1872.
[16] Keutgen XM, Nilubol N, Glanville J, et al. Resection of primary tumor site is associated with prolonged survival in metastatic nonfunctioning pancreatic neuroendocrine tumors[J]. Surgery, 2016, 159(1): 311-318. doi:10.1016/j.surg.2015.05.042.
[17] Hüttner FJ, Schneider L, Tarantino I, et al. Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis[J]. Langenbecks Arch Surg, 2015, 400(6): 715-723. doi:10.1007/s00423-015-1323-x.
[18] Ruan RW, Chen SS, Tao YL, et al. Retrospective analysis of predictive factors for lymph node metastasis in superficial esophageal squamous cell carcinoma[J]. Sci Rep, 2021, 11: 16544. doi:10.1038/s41598-021-96088-y.
[19] Chen XB, Guo TT. Development of a nomogram for predicting survival of patients with ovarian serous cystadenocarcinoma after surgery based on SEER database[J]. J Zhejiang Univ(Med Sci), 2021, 50(3): 369-374. doi:10.3724/zdxbyxb-2021-0188.
[1] LI Jingjing, WU Xinxin, MAO Ning, ZHENG Guibin, MU Yakui, CHU Tongpeng, JIA Chuanliang, ZHENG Haitao, MI Jia, SONG Xicheng. CT-based radiomics nomogram for the preoperative prediction of central lymph node metastases of papillary thyroid carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 51-59.
[2] WANG YayueOverview,SUN JuanGuidance. Research progress on differentially-expressed protein kinases and inhibitors in hypopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(1): 119-124.
[3] This study aims to evaluate the level of expression of cyclin E2 in hypopharyngeal cancer and its relationship with clinical characteristics as well as prognosis. MethodsThe protein levels of cyclin E2 in tumor tissues and adjacent normal tissues were assessed by immunohistochemistry staining in 50 cases of hypopharyngeal cancer. The relationship between the expression level of cyclin E2 and clinical data was analyzed using the SPSS software. ResultsProtein levels of cyclin E2 in hypopharyngeal cancer were higher than protein levels of cyclin E2 in normal tissue(Z=-5.764,P=0.000). The cyclin E2 level in tumor tissue correlated with the tumor staging(Z=-1.995, P=0.046)and lymph node metastasis(Z=-2.176, P=0.030). The 5-year survival rates of patients with cyclin E2 positive and negative expression were 40.2% and 81.8%, respectively. Patients with high expression levels of cyclin E2 had a lower survival rate(χ=6.317, P=0.012). ConclusionThe abnormal expression of cyclin E2 protein in tumor tissues indicates that cyclin E2 may be involved in the development of hypopharyngeal cancer and could be a potential diagnostic and prognostic molecular marker.. Expression of cyclin E2 in hypopharyngeal cancer and its clinical significance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(5): 132-137.
[4] YUE Jianlin, LIN Yun, JIANG Zhen, LI Xuexin, SUN Ruijie, PAN Xinliang, LIU Dayu. Application of the hemi-tongue root flap for the repair of lateral defects in the pharyngeal cavity [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(1): 63-66.
[5] HUANG He, OUYANG Hui. Risk factors and prognosis of esophageal cancer with hypopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(4): 82-86.
[6] JIANG Chang, XU Chengbi, XIN Ding, JU Yang, LI Hongyan, WANG Jinyue.. Axillary lymph node metastasis in patient with hypopharyngeal carcinoma: report of 1 case and literature review. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(1): 90-92.
[7] QIAN Ye, LEI Da-peng, JIN Tong, LIU Da-yu, XU Feng-lei, PAN Xin-liang. Expression of Slit2 and its correlation with lymphatic vessel density in hypopharyngeal squamous cell carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(5): 12-15.
[8] YE Ping, SUN Rui-jie, JIN Tong, QIAN Ye, WEI Dong-min, PAN Xin-liang. Expression and significance of Caveolin-1 in hypopharyngeal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(5): 22-24.
[9] LIN Bin,WANG Hui-ge . Hypopharynx-esophageal carcinoma misdiagnosed as thyroid disease: a clinic analysis of 4 cases [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(3): 22-24.
[10] CAO Han-hai1, DING Hai-xia2, PENG Hong-juan3. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2011, 25(3): 25-27.
[11] L Mei1, DONG Pin2, SHE Cui-ping3, DU Cui-ping1, LI Yong1, XU Er-dong1. Differentially expressed genes in 3 cases of hypopharyngeal carcinoma and  normal tissues by cDNA microarray [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(5): 5-.
[12] GAO Xingqiang1, ZHAO Dean1, FANG Zheng2, YU Xiuyi2
.

hypopharynx and thoracic segmentesophagus synchronous multiple primary carcinoma: a clinical

analysis of 5 cases

[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2009, 23(2): 24-26 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!